tiprankstipranks
Sellas Life Sciences Group (SLS)
NASDAQ:SLS
US Market
SLS
SELLAS Life Sciences Group
RESEARCH TOOLSreports

SELLAS Life Sciences Group (SLS) Financial Statements

Compare
1,378 Followers

SELLAS Life Sciences Group Financial Overview

SELLAS Life Sciences Group's market cap is currently $888.93M. The company's EPS TTM is $-0.05; its P/E ratio is ―; SELLAS Life Sciences Group is scheduled to report earnings on March 19, 2026, and the estimated EPS forecast is $-0.06. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 1.00M$ 7.60M
Gross Profit$ 0.00$ 0.00$ 0.00$ 900.00K$ 7.40M
Operating Income$ -28.27M$ -31.51M$ -37.87M$ -41.95M$ -25.29M
EBITDA$ -28.27M$ 632.00K$ 529.00K$ -31.49M$ -18.32M
Net Income$ -26.86M$ -30.88M$ -37.34M$ -41.30M$ -20.70M
Balance Sheet
Cash & Short-Term Investments$ 71.89M$ 13.89M$ 2.53M$ 17.13M$ 21.45M
Total Assets$ 78.34M$ 19.43M$ 6.22M$ 20.94M$ 26.43M
Total Debt$ 1.00M$ 1.00M$ 906.00K$ 945.00K$ 808.00K
Net Debt$ -70.89M$ -12.88M$ -1.62M$ -16.18M$ -20.65M
Total Liabilities$ 7.47M$ 9.97M$ 14.20M$ 16.09M$ 6.08M
Stockholders' Equity$ 70.87M$ 9.46M$ -7.98M$ 4.85M$ 20.35M
Cash Flow
Free Cash Flow$ -28.39M$ -35.40M$ -36.91M$ -28.31M$ -26.02M
Operating Cash Flow$ -28.39M$ -35.40M$ -31.41M$ -23.81M$ -26.02M
Investing Cash Flow$ 0.00$ 0.00$ -5.50M$ -4.50M$ 0.00
Financing Cash Flow$ 86.30M$ 46.76M$ 22.32M$ 24.08M$ 12.07M
Currency in USD

SELLAS Life Sciences Group Earnings and Revenue History

Income Statement >

SELLAS Life Sciences Group Debt to Assets

Balance Sheet >

SELLAS Life Sciences Group Cash Flow

Cash Flow >

SELLAS Life Sciences Group Forecast EPS vs Actual EPS

Earnings >